Patrick Kirchweger

431 total citations
19 papers, 105 citations indexed

About

Patrick Kirchweger is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick Kirchweger has authored 19 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick Kirchweger's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (6 papers) and Gallbladder and Bile Duct Disorders (5 papers). Patrick Kirchweger is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (6 papers) and Gallbladder and Bile Duct Disorders (5 papers). Patrick Kirchweger collaborates with scholars based in Austria, Liechtenstein and Germany. Patrick Kirchweger's co-authors include Helwig Wundsam, R. Függer, Holger Rumpold, Gerald Webersinke, Alexander Kupferthaler, Andreas Petzer, Emina Jukic, C. Lorber, Klaus Lechner and Bernhard Doleschal and has published in prestigious journals such as Scientific Reports, Journal of Vascular Surgery and Cancers.

In The Last Decade

Patrick Kirchweger

18 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Kirchweger Austria 7 59 39 36 33 15 19 105
Kathryn Lindsey United States 8 59 1.0× 20 0.5× 28 0.8× 14 0.4× 14 0.9× 22 130
Annick Chevalier-Place France 6 56 0.9× 15 0.4× 48 1.3× 27 0.8× 19 1.3× 7 148
Iolanda Capone Italy 6 55 0.9× 29 0.7× 42 1.2× 22 0.7× 31 2.1× 16 109
Mingzhe Xiao China 6 45 0.8× 20 0.5× 38 1.1× 29 0.9× 7 0.5× 32 108
Martha Perisoglou United Kingdom 3 49 0.8× 19 0.5× 69 1.9× 19 0.6× 17 1.1× 6 150
A. Poveda Velasco Spain 6 21 0.4× 11 0.3× 37 1.0× 31 0.9× 11 0.7× 8 112
Oluchi Oke United States 5 73 1.2× 26 0.7× 24 0.7× 26 0.8× 9 0.6× 12 120
Helwig Wundsam Austria 9 142 2.4× 37 0.9× 52 1.4× 159 4.8× 11 0.7× 27 212
Marcin Zeman Poland 6 85 1.4× 25 0.6× 13 0.4× 64 1.9× 17 1.1× 25 185

Countries citing papers authored by Patrick Kirchweger

Since Specialization
Citations

This map shows the geographic impact of Patrick Kirchweger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Kirchweger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Kirchweger more than expected).

Fields of papers citing papers by Patrick Kirchweger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Kirchweger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Kirchweger. The network helps show where Patrick Kirchweger may publish in the future.

Co-authorship network of co-authors of Patrick Kirchweger

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Kirchweger. A scholar is included among the top collaborators of Patrick Kirchweger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Kirchweger. Patrick Kirchweger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Reichinger, Andreas, Hossein Taghizadeh, Patrick Kirchweger, et al.. (2025). NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data. ESMO Open. 10(10). 105827–105827.
2.
Doleschal, Bernhard, Alexander Kupferthaler, Gerald Webersinke, et al.. (2024). Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment. Cancers. 16(23). 3960–3960. 2 indexed citations
3.
Taghizadeh, Hossein, Gerald Webersinke, Stefan Kasper, et al.. (2024). Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data. Cancer Immunology Immunotherapy. 73(12). 251–251. 2 indexed citations
4.
Fritz, Ashley Virginia, et al.. (2024). Lost gallstones during laparoscopic cholecystectomy as a common but underestimated complication—case report and review of the literature. Frontiers in Surgery. 11. 1375502–1375502. 1 indexed citations
5.
Kirchweger, Patrick, et al.. (2023). The Rate of Avoidable Pancreatic Resections at a High-Volume Center: An Internal Quality Control and Critical Review. Journal of Clinical Medicine. 12(4). 1625–1625. 1 indexed citations
6.
Doleschal, Bernhard, Hossein Taghizadeh, Jakob M. Riedl, et al.. (2023). Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer. ESMO Open. 8(6). 102064–102064. 1 indexed citations
7.
Spaun, Georg, et al.. (2023). Endoscopic Transmural Therapy of Pancreatic Fistulas in an Interdisciplinary Setting—A Retrospective Data Analysis. Journal of Clinical Medicine. 12(13). 4531–4531. 1 indexed citations
8.
Doleschal, Bernhard, et al.. (2023). Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis. Oncology. 102(2). 107–113. 3 indexed citations
9.
Doleschal, Bernhard, Hossein Taghizadeh, Gerald Webersinke, et al.. (2023). Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment. Scientific Reports. 13(1). 15421–15421. 9 indexed citations
11.
Doleschal, Bernhard, Patrick Kirchweger, Alexander Kupferthaler, et al.. (2023). Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 15. 2645198–2645198. 1 indexed citations
12.
Kirchweger, Patrick, Alexander Kupferthaler, Gerald Webersinke, et al.. (2022). Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer. Frontiers in Oncology. 12. 902177–902177. 14 indexed citations
13.
Kirchweger, Patrick, et al.. (2022). Systematic literature review and meta-analysis of Clostridium septicum aortitis. Journal of Vascular Surgery. 76(2). 595–604.e1. 3 indexed citations
14.
Kirchweger, Patrick, et al.. (2022). Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies. World Journal of Clinical Oncology. 13(6). 473–484. 9 indexed citations
15.
Kirchweger, Patrick, Alexander Kupferthaler, Gerald Webersinke, et al.. (2021). Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage. European Journal of Surgical Oncology. 48(5). 1046–1053. 16 indexed citations
16.
Wundsam, Helwig, et al.. (2021). Long-Term Quality of Life after Pancreatic Surgery for Intraductal Papillary Mucinous Neoplasm. European Surgical Research. 62(2). 80–87. 3 indexed citations
17.
Kirchweger, Patrick, et al.. (2020). Total resection of a giant retroperitoneal and mediastinal ganglioneuroma—case report and systematic review of the literature. World Journal of Surgical Oncology. 18(1). 248–248. 14 indexed citations
18.
Rumpold, Holger, et al.. (2020). Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort. Acta Oncologica. 60(2). 180–186. 8 indexed citations
19.
Willfort, Andrea, C. Lorber, S. Kapiotis, et al.. (1993). Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF). Annals of Hematology. 66(5). 241–244. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026